Generic Medications on the Horizon: How Canada's Patent Cliff Could Put Money Back in Your Pocket
Several blockbuster brand-name medications are set to lose patent protection in Canada throughout 2024 and 2025, opening the door to lower-cost generic alternatives for millions of patients. Understanding which drugs are affected—and how to navigate the transition—could meaningfully reduce what you pay at the pharmacy counter. This guide breaks down the timeline, the therapeutic categories most impacted, and how to have an informed conversation with your prescriber.